Athersys Inc (ATHXQ)

[Ecomike]

ATHX is showing signs of a deep discount bottom formed.

Trading the $2 to $3 range, chart-able, with a $39/share 52 week high.
News is out, of income, 1.9 Million dollars...

https://ih.advfn.com/stock-market/NASDAQ/athersys-ATHX/stock-news/89039065/current-report-filing-8-k

And an institution invested 12 Mil dollars a month ago, about 10 days before the R/S at a Post R/S cost of $6.25/share.

I like my odds buying down here....

" Athersys, Inc. (“we” or the “Company”) has a licensing agreement with HEALIOS K.K. (“Healios”) to primarily develop and commercialize our cell therapy technologies for certain disease indications in Japan. Under the framework agreement, we were entitled to a $3.0 million milestone payment from Healios. Additionally, under the framework agreement, we are obligated to pay Healios $1.1 million this year. On September 8, 2022, we received a payment of $1.9 million from Healios, which represents the milestone payment net of amounts owed to Healios under the framework agreement.

Athersys and Healios remain committed to the advancement of MultiStem in Japan for both the ischemic stroke and ARDS programs and we will continue to work closely with Healios and the Pharmaceuticals and Medical Devices Agency on an appropriate path forward."

The OS is now just 12 Millions shares folks (25:1 R/S) to avoid Nasdaq delisting about 2 weeks ago).